The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension
Open accessAbstract
Rationale: Pulmonary arterial hypertension (PAH) is an incurable disease associated with viral infections and connective tissue diseases. The relationship between inflammation and disease pathogenesis in these disorders remains poorly understood. Objective: To determine whether immune dysregulation due to absent T-cell populations directly contributes to the development of PAH. Methods and Results: Vascular endothelial growth factor receptor 2 (VEGFR2) blockade induced significant pulmonary endothelial apoptosis in T-cell-deficient rats but not in immune-reconstituted (IR) rats. T cell–lymphopenia in association with VEGFR2 blockade resulted in periarteriolar inflammation with macrophages, and B cells even prior to vascular remodeling and elevated pulmonary pressures. IR prevented early inflammation and attenuated PAH development. IR with either CD8 T cells alone or with CD4-depleted spleen cells was ineffective in preventing PAH, whereas CD4-depleting immunocompetent euthymic animals increased PAH susceptibility. IR with either CD4 + CD25 hi or CD4 + CD25 − T cell subsets prior to vascular injury attenuated the development of PAH. IR limited perivascular inflammation and endothelial apoptosis in rat lungs in association with increased FoxP3 + , IL-10- and TGF-β-expressing CD4 cells, and upregulation of pulmonary bone morphogenetic protein receptor type 2 (BMPR2)–expressing cells, a receptor that activates endothelial cell survival pathways. Conclusions: PAH may arise when regulatory T-cell (Treg) activity fails to control endothelial injury. These studies suggest that regulatory T cells normally function to limit vascular injury and may protect against the development of PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,820
Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri1027 · Cited by 1,317
CD4 + CD25 + Foxp3 + regulatory T cells induce alternative activation of human monocytes/macrophages
Tiemessen, M. M., Jagger, A. L., Evans, H. G., van Herwijnen, M. J. C., John, S., & Taams, L. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706832104 · Cited by 852
TARASEVICIENE‐STEWART, L., KASAHARA, Y., ALGER, L., HIRTH, P., MAHON, G. M., WALTENBERGER, J., VOELKEL, N. F., & TUDER, R. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0343com · Cited by 817
Self-citationHumbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Inflammation, Growth Factors, and Pulmonary Vascular Remodeling
Hassoun, P. M., Mouthon, L., Barberà, J. A., Eddahibi, S., Flores, S. C., Grimminger, F., Jones, P. L., Maitland, M. L., Michelakis, E. D., Morrell, N. W., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.006 · Cited by 710
Self-citationAtkinson, C., Stewart, S., Upton, P. D., Machado, R., Thomson, J. R., Trembath, R. C., & Morrell, N. W. (2002) · Circulation · doi:10.1161/01.cir.0000012754.72951.3d · Cited by 697
Interleukin-6 Overexpression Induces Pulmonary Hypertension
Steiner, M. K., Syrkina, O. L., Kolliputi, N., Mark, E. J., Hales, C. A., & Waxman, A. B. (2009) · Circulation Research · doi:10.1161/circresaha.108.182014 · Cited by 655
Nakamura, K., Kitani, A., Fuss, I., Pedersen, A., Harada, N., Nawata, H., & Strober, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.834 · Cited by 630
Inflammation in pulmonary arterial hypertension
Dorfmüller, P., Perros, F., Balabanian, K., & Humbert, M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00038903 · Cited by 594
Sun, L., Tran, N., Tang, F., App, H., Hirth, P., McMahon, G., & Tang, C. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980123i · Cited by 489
In vivo switch to IL-10–secreting T regulatory cells in high dose allergen exposure
Meiler, F., Zumkehr, J., Klunker, S., Rückert, B., Akdis, C. A., & Akdis, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080193 · Cited by 411
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Brusko, T. M., Putnam, A. L., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00637.x · Cited by 374
Zheng, S. G., Wang, J., & Horwitz, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7112 · Cited by 356
Primary Pulmonary Hypertension in HIV Infection
Speich, R., Jenni, R., Opravil, M., Pfab, M., & Russi, E. W. (1991) · Chest · doi:10.1378/chest.100.5.1268 · Cited by 354
Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells
Sakao, S., Taraseviciene‐Stewart, L., Lee, J. D., Wood, K., Cool, C. D., & Voelkel, N. F. (2005) · The FASEB Journal · doi:10.1096/fj.04-3261fje · Cited by 301
Self-citationModulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells
Taams, L. S., van Amelsfort, J. M. R., Tiemessen, M. M., Jacobs, K. M. G., de Jong, E. C., Akbar, A. N., Bijlsma, J. W. J., & Lafeber, F. P. J. G. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.12.006 · Cited by 289
Suppressor T cells – they’re back and critical for regulation of autoimmunity!
Chatenoud, L., Salomon, B., & Bluestone, J. A. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820112.x · Cited by 273
Ghiringhelli, F., Ménard, C., Martin, F., & Zitvogel, L. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00445.x · Cited by 273
Autoimmunity and pulmonary hypertension: a perspective
Nicolls, M. R., Taraseviciene-Stewart, L., Rai, P. R., Badesch, D. B., & Voelkel, N. F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00045705 · Cited by 261
Self-citationThe Cancer Paradigm of Severe Pulmonary Arterial Hypertension
Rai, P. R., Cool, C. D., King, J. A. C., Stevens, T., Burns, N., Winn, R. A., Kasper, M., & Voelkel, N. F. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1369pp · Cited by 258
Self-citationHong, K.-H., Lee, Y. J., Lee, E., Park, S. O., Han, C., Beppu, H., Li, E., Raizada, M. K., Bloch, K. D., & Oh, S. P. (2008) · Circulation · doi:10.1161/circulationaha.107.736801 · Cited by 248
Fujita, M., Shannon, J. M., Irvin, C. G., Fagan, K. A., Cool, C., Augustin, A., & Mason, R. J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.1.l39 · Cited by 223
Montagnoli, C., Fallarino, F., Gaziano, R., Bozza, S., Bellocchio, S., Zelante, T., Kurup, W. P., Pitzurra, L., Puccetti, P., & Romani, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1712 · Cited by 203
Bonelli, M., Savitskaya, A., Steiner, C.-W., Rath, E., Smolen, J. S., & Scheinecker, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1689 · Cited by 195
CD4+CD25+ Regulatory T Cells Control Innate Immune Reactivity after Injury
Murphy, T. J., Choileain, N. N., Zang, Y., Mannick, J. A., & Lederer, J. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2957 · Cited by 188
Radstake, T. R. D. J., van Bon, L., Broen, J., Wenink, M., Santegoets, K., Deng, Y., Hussaini, A., Simms, R., Cruikshank, W. W., & Lafyatis, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005981 · Cited by 185
Absence of T Cells Confers Increased Pulmonary Arterial Hypertension and Vascular Remodeling
Taraseviciene-Stewart, L., Nicolls, M. R., Kraskauskas, D., Scerbavicius, R., Burns, N., Cool, C., Wood, K., Parr, J. E., Boackle, S. A., & Voelkel, N. F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1189oc · Cited by 182
Self-citationInteraction of interleukin-6 and the BMP pathway in pulmonary smooth muscle
Hagen, M. E., Fagan, K., Steudel, W., Carr, M., Lane, K. B., Rodman, D. M., & West, J. D. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00197.2006 · Cited by 165
Role of the TGF-β/Alk5 Signaling Pathway in Monocrotaline-induced Pulmonary Hypertension
Zaiman, A., Podowski, M., Medicherla, S., Gordy, K., Xu, F., Zhen, L., Shimoda, L. A., Neptune, E., Higgins, L. S., Murphy, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1083oc · Cited by 161
Mahajan, D., Wang, Y., Qin, X., Wang, Y., Zheng, G., Wang, Y. M., Alexander, S. I., & Harris, D. C. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080842 · Cited by 133
Pulmonary hypertension and inflammation
Tuder, R. M., & Voelkel, N. F. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90020-8 · Cited by 128 · cited 3×
“21,22 The proposed mechanisms by which Tregs control inflammation are numerous and involve several basic mechanisms including (1) secretion of antiinflammatory cytokines (most notably TGF- and IL-10), (2) cytolysis of effector T cells, (3) metabolic disruption of effector cells (for example, by serving as an IL-2 “sin…”
Self-citationTargeting TNF for Treatment of Cancer and Autoimmunity
Sethi, G., Sung, B., Kunnumakkara, A. B., & Aggarwal, B. B. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-89520-8_3 · Cited by 126
McKinley, L., Logar, A., McAllister, F. M., Zheng, M., Steele, C. H., & Kolls, J. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6215 · Cited by 120
Rolstad, B. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1840113.x · Cited by 113
Ito, T., Okada, T., Miyashita, H., Nomoto, T., Nonaka‐Sarukawa, M., Uchibori, R., Maeda, Y., Urabe, M., Mizukami, H., Kume, A., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.153023 · Cited by 112
TGFβ1 and Treg cells: alliance for tolerance
Bommireddy, R., & Doetschman, T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.08.005 · Cited by 108
T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension
Austin, E. D., Rock, M. T., Mosse, C. A., Vnencak‐Jones, C. L., Yoder, S. M., Robbins, I. M., Loyd, J. E., & Meyrick, B. O. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.10.004 · Cited by 100
Hypoxia induces different genes in the lungs of rats compared with mice
Hoshikawa, Y., Nana-Sinkam, P. S., Moore, M. D., Sotto-Santiago, S. M., Phang, T., Keith, R. L., Morris, K. G., Kondo, T., Tuder, R. M., Voelkel, N. F., et al. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00081.2001 · Cited by 96
Self-citationBenvéniste, O., Cherin, P., Maisonobe, T., Merat, R., Chosidow, O., Mouthon, L., Guillevin, L., Flahault, A., Burland, M.-C., Klatzmann, D., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3521 · Cited by 85
Innate Immunity in the Therapeutic Actions of Endothelial Progenitor Cells in Pulmonary Hypertension
Ormiston, M. L., Deng, Y., Stewart, D. J., & Courtman, D. W. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0152oc · Cited by 81
Shih, F. F., Mandik‐Nayak, L., Wipke, B. T., & Allen, P. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031137 · Cited by 71
Mizobuchi, T., Yasufuku, K., Zheng, Y., Haque, M. A., Heidler, K. M., Woods, K., Smith, G. N., Cummings, O. W., Fujisawa, T., Blum, J. S., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1140 · Cited by 67
Mandl, T., Bredberg, A. C. A., Jacobsson, L., Manthorpe, R., & Henriksson, G. (2004) · PubMed · Cited by 59
Athymic Nude Rats Develop Severe Pulmonary Hypertension following Monocrotaline Administration
Miyata, M., Sakuma, F., Ito, M., Ohira, H., Sato, Y., & Kasukawa, R. (2000) · International Archives of Allergy and Immunology · doi:10.1159/000024324 · Cited by 54
Hall, S., Brogan, P. A., Haworth, S. G., & Klein, N. J. (2009) · Thorax · doi:10.1136/thx.2008.106435 · Cited by 50
Autoimmune Diseases as the Loss of Active “Self‐Control”
Bach, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1254.017 · Cited by 49
Hillebrands, J., Whalen, B. J., Visser, J. T. J., Koning, J. J., Bishop, K. D., Leif, J., Rozing, J., Mordes, J. P., Greiner, D. L., & Rossini, A. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7820 · Cited by 39
Peripheral blood T-lymphocyte subsets in autoimmune thyroid disease.
Covas, M., Esquerda, A., Garcia-Rico, A., & Mahy, N. (1992) · PubMed · Cited by 29
Aiello, S., Cassis, P., Cassis, L., Tomasoni, S., Benigni, A., Pezzotta, A., Cavinato, R. A., Cugini, D., Azzollini, N., Mister, M., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000251808.91901.c3 · Cited by 25
Cited by
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Self-citationPulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Molecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60658 · Cited by 653
Self-citationFK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
Spiekerkoetter, E., Tian, X., Cai, J., Hopper, R. K., Sudheendra, D., Li, C. G., El-Bizri, N., Sawada, H., Haghighat, R., Chan, R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65592 · Cited by 449
Self-citationRegulatory T cells in cardiovascular diseases
Meng, X., Yang, J., Dong, M., Zhang, K., Tu, E., Gao, Q., Chen, W., Zhang, C., & Zhang, Y. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.169 · Cited by 402
Metadata
- Authors
- Tamosiuniene, R., Tian, W., Dhillon, G., Wang, L., Sung, Y. K., Gera, L., Patterson, A. J., Agrawal, R., Rabinovitch, M., Ambler, K., Long, C. S., Voelkel, N. F., & Nicolls, M. R.
- Venue
- Circulation Research
- Published
- 2011-09-30
- Volume
- 109
- Issue
- 8
- Pages
- 867-879
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2165494158
- Cited by
- 306
- References
- 55
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.